On Monday, Barclays reaffirmed its Overweight rating on Twist Bioscience (NASDAQ:TWST) with a steady price target of $45.00.... On Monday, Evercore ISI made adjustments to Twist Bioscience’s ...

Story May 5 - Mammoth Biosciences: The California biotech has laid off 24 employees as part of a "strategic alignment," a spokesperson told Fierce Biotech. The CRISPR-focused company is working to ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...